Procambarus clarkii strain Jiangsu linkage group LG92, ASM2042438v2, whole genome shotgun sequence.
Procambarus clarkii (red swamp crayfish)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Astacidea; Astacoidea; Cambaridae; Procambarus.
A chromosome-level reference genome of red swamp crayfish Procambarus clarkii provides insights into the gene families regarding growth or development in crustaceans
REFSEQ INFORMATION: The reference sequence is identical to\nCM035564.1.\nAssembly name: ASM2042438v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Freshwater Fisheries Research\nInstitute of Jiangsu Province, Nanjing 210017, China on 2021/10/12.\nThe original whole-genome shotgun project has the accession\nJAIWQB000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Freshwater Fisheries Research Institute\n of Jiangsu Province, Nanjing 210017,\n China\nAssembly Method :: LACHESIS v. may-2020\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 100.0x\nSequencing Technology :: PacBio RS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Procambarus clarkii Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123746988, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC123746988, transcript variant X2
uncharacterized protein LOC123746988 isoform X1
uncharacterized protein LOC123746988 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
putative nuclease HARBI1, transcript variant X1
putative nuclease HARBI1, transcript variant X2
putative nuclease HARBI1, transcript variant X3
uncharacterized LOC123746991, transcript variant X4
uncharacterized LOC123746991, transcript variant X3
uncharacterized LOC123746991, transcript variant X2
uncharacterized LOC123746991, transcript variant X1
uncharacterized LOC123746991, transcript variant X5
uncharacterized protein LOC123746991 isoform X4
uncharacterized protein LOC123746991 isoform X3
uncharacterized protein LOC123746991 isoform X2
uncharacterized protein LOC123746991 isoform X1
uncharacterized protein LOC123746991 isoform X5
guanine nucleotide-binding protein subunit gamma 4-like
basic salivary proline-rich protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123746994, transcript variant X2
uncharacterized LOC123746994, transcript variant X3
uncharacterized LOC123746994, transcript variant X4
uncharacterized LOC123746994, transcript variant X1
uncharacterized LOC123746998, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC123746998, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC123746998, transcript variant X2
uncharacterized LOC123746998, transcript variant X1
uncharacterized LOC123746998, transcript variant X5
uncharacterized LOC123746998, transcript variant X6
uncharacterized protein LOC123746998 isoform X2
uncharacterized protein LOC123746998 isoform X3
uncharacterized protein LOC123746998 isoform X1
uncharacterized protein LOC123746998 isoform X4
uncharacterized protein LOC123746998 isoform X5
centrosomal protein of 135 kDa-like, transcript variant X3
centrosomal protein of 135 kDa-like, transcript variant X1
centrosomal protein of 135 kDa-like, transcript variant X2
centrosomal protein of 135 kDa-like, transcript variant X4
centrosomal protein of 135 kDa-like isoform X1
centrosomal protein of 135 kDa-like isoform X2
uncharacterized LOC123746997, transcript variant X2
uncharacterized LOC123746997, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
neuronal acetylcholine receptor subunit alpha-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
nose resistant to fluoxetine protein 6-like
uncharacterized LOC123747003, transcript variant X1
uncharacterized LOC123747003, transcript variant X2
uncharacterized protein LOC123747003 isoform X1
uncharacterized protein LOC123747003 isoform X2
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X2
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X1
rab proteins geranylgeranyltransferase component A 1-like isoform X1
rab proteins geranylgeranyltransferase component A 1-like isoform X2
uncharacterized LOC123747005, transcript variant X2
uncharacterized LOC123747005, transcript variant X1
negative elongation factor D-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 88 samples with support for all annotated introns
negative elongation factor D-like isoform X1
negative elongation factor D-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
negative elongation factor D-like isoform X2
neuroblast differentiation-associated protein AHNAK-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
nucleobindin-2-like, transcript variant X1
nucleobindin-2-like, transcript variant X5
nucleobindin-2-like, transcript variant X6
nucleobindin-2-like, transcript variant X7
nucleobindin-2-like, transcript variant X3
nucleobindin-2-like, transcript variant X2
nucleobindin-2-like, transcript variant X4
uncharacterized protein LOC123747006 isoform X1
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphatidylinositol N-acetylglucosaminyltransferase subunit Q-like, transcript variant X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit Q-like, transcript variant X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit Q-like
integrin beta-PS-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
integrin beta-PS-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
uncharacterized LOC123747016, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123747016, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC123747016, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC123747016, transcript variant X1
peripheral plasma membrane protein CASK-like, transcript variant X2
peripheral plasma membrane protein CASK-like, transcript variant X1
peripheral plasma membrane protein CASK-like, transcript variant X4
peripheral plasma membrane protein CASK-like, transcript variant X3
peripheral plasma membrane protein CASK-like, transcript variant X5
peripheral plasma membrane protein CASK-like, transcript variant X6
peripheral plasma membrane protein CASK-like isoform X6
peripheral plasma membrane protein CASK-like isoform X4
peripheral plasma membrane protein CASK-like isoform X3
peripheral plasma membrane protein CASK-like isoform X5
peripheral plasma membrane protein CASK-like isoform X2
peripheral plasma membrane protein CASK-like isoform X1
soluble scavenger receptor cysteine-rich domain-containing protein SSC5D-like
tetra-peptide repeat homeobox protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
peripheral plasma membrane protein CASK-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
cell wall integrity and stress response component 1-like
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial-like, transcript variant X1
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial-like, transcript variant X2
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial-like isoform X1
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial-like isoform X2
uncharacterized LOC123747018, transcript variant X1
uncharacterized LOC123747018, transcript variant X2
uncharacterized LOC123747020, transcript variant X3
uncharacterized LOC123747020, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123747020, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123747019, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123747019, transcript variant X1
uncharacterized LOC123747022, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123747022, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123747022, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123747022, transcript variant X1
uncharacterized protein LOC123747022 isoform X3
uncharacterized protein LOC123747022 isoform X2
uncharacterized protein LOC123747022 isoform X4
uncharacterized protein LOC123747022 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123746933, transcript variant X1
uncharacterized LOC123746933, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123746933, transcript variant X2
solute carrier family 35 member E1 homolog, transcript variant X1
solute carrier family 35 member E1 homolog, transcript variant X2
solute carrier family 35 member E1 homolog isoform X1
solute carrier family 35 member E1 homolog isoform X2
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
NK1 transcription factor-related protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 64% coverage of the annotated genomic feature by RNAseq alignments
zwei Ig domain protein zig-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zwei Ig domain protein zig-3-like, transcript variant X1
zwei Ig domain protein zig-3-like isoform X2
zwei Ig domain protein zig-3-like isoform X1
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial-like, transcript variant X1
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial-like, transcript variant X2
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial-like
arrestin domain-containing protein 17-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 94 samples with support for all annotated introns
arrestin domain-containing protein 17-like, transcript variant X1
arrestin domain-containing protein 17-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 85 samples with support for all annotated introns
arrestin domain-containing protein 17-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
arrestin domain-containing protein 17-like, transcript variant X3
arrestin domain-containing protein 2-like isoform X1
arrestin domain-containing protein 17-like isoform X2
arrestin domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
high mobility group protein 20A-like, transcript variant X3
high mobility group protein 20A-like, transcript variant X4
high mobility group protein 20A-like isoform X3
high mobility group protein 20A-like, transcript variant X2
high mobility group protein 20A-like, transcript variant X7
high mobility group protein 20A-like, transcript variant X5
high mobility group protein 20A-like, transcript variant X8
high mobility group protein 20A-like, transcript variant X6
high mobility group protein 20A-like isoform X4
high mobility group protein 20A-like, transcript variant X1
high mobility group protein 20A-like isoform X1
high mobility group protein 20A-like isoform X2
high mobility group protein 20A-like isoform X5
NADH-cytochrome b5 reductase 2-like, transcript variant X1
NADH-cytochrome b5 reductase 2-like, transcript variant X2
NADH-cytochrome b5 reductase 2-like isoform X1
NADH-cytochrome b5 reductase 2-like isoform X2
phospholipid hydroperoxide glutathione peroxidase-like
uncharacterized LOC123747037, transcript variant X2
uncharacterized LOC123747037, transcript variant X1
uncharacterized protein LOC123747037 isoform X1
uncharacterized protein LOC123747037 isoform X2
protein MMS22-like, transcript variant X1
protein MMS22-like, transcript variant X2
tetratricopeptide repeat protein 27-like
TATA-binding protein-associated factor 2N-like, transcript variant X1
TATA-binding protein-associated factor 2N-like, transcript variant X3
TATA-binding protein-associated factor 2N-like, transcript variant X2
TATA-binding protein-associated factor 2N-like isoform X1
heterogeneous nuclear ribonucleoprotein A3 homolog 1-like isoform X3
keratin, type I cytoskeletal 9-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
UBX domain-containing protein 6-like, transcript variant X5
UBX domain-containing protein 6-like, transcript variant X2
UBX domain-containing protein 6-like, transcript variant X1
UBX domain-containing protein 6-like, transcript variant X3
UBX domain-containing protein 6-like, transcript variant X4
polyprenol reductase-like, transcript variant X2
polyprenol reductase-like, transcript variant X1
polyprenol reductase-like, transcript variant X3
polyprenol reductase-like, transcript variant X4
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
uncharacterized aarF domain-containing protein kinase 2-like isoform X1
uncharacterized aarF domain-containing protein kinase 2-like isoform X2
uncharacterized LOC123747047, transcript variant X2
uncharacterized LOC123747047, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC123747047, transcript variant X1
uncharacterized protein LOC123747047 isoform X1
uncharacterized protein LOC123747047 isoform X2
uncharacterized protein LOC123747047 isoform X3
iron-sulfur clusters transporter ABCB7, mitochondrial-like, transcript variant X1
iron-sulfur clusters transporter ABCB7, mitochondrial-like, transcript variant X2
iron-sulfur clusters transporter ABCB7, mitochondrial-like isoform X1
iron-sulfur clusters transporter ABCB7, mitochondrial-like isoform X2
uracil phosphoribosyltransferase homolog, transcript variant X2
uracil phosphoribosyltransferase homolog, transcript variant X1
uracil phosphoribosyltransferase homolog
cytochrome c oxidase subunit 5A, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
IQ and AAA domain-containing protein 1-like
uncharacterized LOC123747055, transcript variant X3
uncharacterized LOC123747055, transcript variant X6
uncharacterized LOC123747055, transcript variant X5
uncharacterized LOC123747055, transcript variant X4
uncharacterized LOC123747055, transcript variant X1
uncharacterized LOC123747055, transcript variant X2
uncharacterized protein LOC123747055 isoform X4
uncharacterized protein LOC123747055 isoform X3
uncharacterized protein LOC123747055 isoform X2
uncharacterized protein LOC123747055 isoform X1
serine--tRNA ligase, mitochondrial-like, transcript variant X2
serine--tRNA ligase, mitochondrial-like, transcript variant X3
serine--tRNA ligase, mitochondrial-like, transcript variant X1
putative uncharacterized protein DDB_G0286901
SUMO-interacting motif-containing protein 1-like
protogenin B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
protogenin B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
carbohydrate sulfotransferase 11-like, transcript variant X3
carbohydrate sulfotransferase 11-like, transcript variant X5
carbohydrate sulfotransferase 11-like, transcript variant X1
carbohydrate sulfotransferase 11-like, transcript variant X2
carbohydrate sulfotransferase 11-like, transcript variant X4
carbohydrate sulfotransferase 11-like isoform X2
carbohydrate sulfotransferase 11-like isoform X1
carbohydrate sulfotransferase 11-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
carbohydrate sulfotransferase 12-like isoform X3
cytosolic 5'-nucleotidase 3-like, transcript variant X1
cytosolic 5'-nucleotidase 3-like, transcript variant X3
cytosolic 5'-nucleotidase 3-like, transcript variant X2
cytosolic 5'-nucleotidase 3-like isoform X1
cytosolic 5'-nucleotidase 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123747064, transcript variant X2
uncharacterized LOC123747064, transcript variant X1
5'-3' exoribonuclease 2 homolog, transcript variant X1
5'-3' exoribonuclease 2 homolog, transcript variant X2
5'-3' exoribonuclease 2 homolog isoform X1
5'-3' exoribonuclease 2 homolog isoform X2
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X1
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X1
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X2
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3C-like, transcript variant X3
protein phosphatase 1 regulatory subunit 3C-like, transcript variant X1
protein phosphatase 1 regulatory subunit 3C-like, transcript variant X4
protein phosphatase 1 regulatory subunit 3C-like, transcript variant X2
protein phosphatase 1 regulatory subunit 3C-like isoform X1
protein phosphatase 1 regulatory subunit 3C-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC123747075, transcript variant X2
uncharacterized LOC123747075, transcript variant X3
uncharacterized LOC123747075, transcript variant X1
uncharacterized protein LOC123747075 isoform X2
uncharacterized protein LOC123747075 isoform X1
cell surface glycoprotein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cell surface glycoprotein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cell surface glycoprotein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cell surface glycoprotein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
cell surface glycoprotein 1-like isoform X1
cell surface glycoprotein 1-like isoform X2
cell surface glycoprotein 1-like isoform X3
cell surface glycoprotein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
plasminogen activator inhibitor 1 RNA-binding protein-like, transcript variant X1
plasminogen activator inhibitor 1 RNA-binding protein-like, transcript variant X3
plasminogen activator inhibitor 1 RNA-binding protein-like, transcript variant X2
plasminogen activator inhibitor 1 RNA-binding protein-like isoform X3
plasminogen activator inhibitor 1 RNA-binding protein-like isoform X1
plasminogen activator inhibitor 1 RNA-binding protein-like isoform X2
uncharacterized LOC123747081, transcript variant X2
uncharacterized LOC123747081, transcript variant X1
uncharacterized protein LOC123747081 isoform X2
uncharacterized protein LOC123747081 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123747083, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC123747083, transcript variant X3
uncharacterized LOC123747083, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC123747083, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
eukaryotic translation initiation factor 3 subunit F-1-like
aldehyde dehydrogenase family 16 member A1-like
solute carrier family 2, facilitated glucose transporter member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
guanine deaminase-like, transcript variant X3
guanine deaminase-like, transcript variant X2
guanine deaminase-like, transcript variant X1
guanine deaminase-like, transcript variant X5
guanine deaminase-like, transcript variant X6
guanine deaminase-like, transcript variant X4
guanine deaminase-like, transcript variant X7
SEC14-like protein 1, transcript variant X1
SEC14-like protein 1, transcript variant X2
SEC14-like protein 1, transcript variant X3
SEC14-like protein 1, transcript variant X4
SEC14-like protein 1, transcript variant X5
SEC14-like protein 1, transcript variant X6
putative uncharacterized protein ENSP00000383309
uncharacterized LOC123747090, transcript variant X1
uncharacterized LOC123747090, transcript variant X5
uncharacterized LOC123747090, transcript variant X2
uncharacterized LOC123747090, transcript variant X7
uncharacterized LOC123747090, transcript variant X6
uncharacterized protein LOC123747090 isoform X1
uncharacterized protein LOC123747090 isoform X5
uncharacterized protein LOC123747090 isoform X2
uncharacterized protein LOC123747090 isoform X7
uncharacterized protein LOC123747090 isoform X6
uncharacterized LOC123747090, transcript variant X4
uncharacterized LOC123747090, transcript variant X3
uncharacterized protein LOC123747090 isoform X3
uncharacterized protein LOC123747090 isoform X4
GSK3B-interacting protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
GSK3B-interacting protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 102 samples with support for all annotated introns
GSK3B-interacting protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
GSK3B-interacting protein-like, transcript variant X7
GSK3B-interacting protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
GSK3B-interacting protein-like isoform X1
GSK3B-interacting protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
GSK3B-interacting protein-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
GSK3B-interacting protein-like isoform X2
RING finger protein 141-like, transcript variant X1
RING finger protein 141-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123747098, transcript variant X1
uncharacterized LOC123747098, transcript variant X2
mitochondrial import inner membrane translocase subunit TIM50-C-like, transcript variant X2
mitochondrial import inner membrane translocase subunit TIM50-C-like, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM50-C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 88 samples with support for all annotated introns
translation initiation factor eIF-2B subunit gamma-like
phytanoyl-CoA dioxygenase domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123747103, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
uncharacterized LOC123747103, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
uncharacterized protein LOC123747103 isoform X1
uncharacterized protein LOC123747103 isoform X2
UDP-glucose 4-epimerase-like, transcript variant X1
UDP-glucose 4-epimerase-like, transcript variant X2
NAD-dependent protein deacylase Sirt4-like, transcript variant X1
NAD-dependent protein deacylase Sirt4-like, transcript variant X3
NAD-dependent protein deacylase Sirt4-like, transcript variant X2
NAD-dependent protein deacylase Sirt4-like